Mechanism Underlying Symptom Benefit With Prucalopride in Gastroparesis
Am J Gastroenterol
.
2019 Dec;114(12):1920-1921.
doi: 10.14309/ajg.0000000000000458.
Authors
Florencia Carbone
1
,
Karen Van den Houte
1
,
Nick Goelen
1
,
Jolien Schol
1
,
Imke Masuy
1
,
Pieter Janssen
1
,
Jan Tack
1
Affiliation
1
TARGID (Translational Research Center for Gastrointestinal Disorders), University of Leuven, Flanders, Belgium.
PMID:
31738287
DOI:
10.14309/ajg.0000000000000458
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Benzofurans*
Cross-Over Studies
Gastric Emptying
Gastroparesis*
Humans
Substances
Benzofurans
prucalopride